ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
Novel GPCR-targeted small molecule therapeutics designed to impact patients around the world Total of $158…